Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.43 USD | -5.11% | -2.56% | +81.74% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.73B |
---|---|---|---|---|---|
Net income 2024 * | -266M | Net income 2025 * | -277M | EV / Sales 2024 * | - |
Net Debt 2024 * | 10.59M | Net cash position 2025 * | 190M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.4
x | P/E ratio 2025 * |
-6.98
x | Employees | 328 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.37% |
Latest transcript on Sana Biotechnology, Inc.
1 day | +4.40% | ||
1 week | +1.03% | ||
Current month | +4.40% | ||
1 month | -25.00% | ||
3 months | -20.18% | ||
6 months | +95.51% | ||
Current year | +91.91% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 18-07-12 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 18-08-31 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 20-04-30 | |
Patrick Yang
BRD | Director/Board Member | 75 | 18-09-30 |
Robert Nelsen
FOU | Founder | 60 | 18-07-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 7.4 | -5.49% | 424 821 |
24-06-05 | 7.83 | +4.40% | 1,083,979 |
24-06-04 | 7.5 | -3.97% | 1,070,184 |
24-06-03 | 7.81 | +4.13% | 1,574,804 |
24-05-31 | 7.5 | -1.45% | 2,569,190 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+91.91% | 1.73B | |
+55.70% | 59.34B | |
+42.78% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- SANA Stock